Staar Surgical Stock Fundamentals
| STAA Stock | USD 28.55 1.87 7.01% |
STAAR Surgical fundamentals help investors to digest information that contributes to STAAR Surgical's financial success or failures. It also enables traders to predict the movement of STAAR Stock. The fundamental analysis module provides a way to measure STAAR Surgical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to STAAR Surgical stock.
At present, STAAR Surgical's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 338.5 M, whereas Depreciation And Amortization is forecasted to decline to about 2.9 M. STAAR | Select Account or Indicator |
STAAR Surgical Company Return On Equity Analysis
STAAR Surgical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current STAAR Surgical Return On Equity | 0.054 |
Most of STAAR Surgical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, STAAR Surgical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
STAAR Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, STAAR Surgical has a Return On Equity of 0.054. This is 100.23% lower than that of the Health Care Equipment & Supplies sector and 100.9% lower than that of the Health Care industry. The return on equity for all United States stocks is 117.42% lower than that of the firm.
STAAR Surgical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining STAAR Surgical's current stock value. Our valuation model uses many indicators to compare STAAR Surgical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across STAAR Surgical competition to find correlations between indicators driving STAAR Surgical's intrinsic value. More Info.STAAR Surgical is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for STAAR Surgical is roughly 1.59 . At present, STAAR Surgical's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the STAAR Surgical's earnings, one of the primary drivers of an investment's value.STAAR Surgical's Earnings Breakdown by Geography
STAAR Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses STAAR Surgical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of STAAR Surgical could also be used in its relative valuation, which is a method of valuing STAAR Surgical by comparing valuation metrics of similar companies.STAAR Surgical is currently under evaluation in return on equity category among its peers.
STAAR Surgical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, STAAR Surgical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to STAAR Surgical's managers, analysts, and investors.Environmental | Governance | Social |
STAAR Fundamentals
| Return On Equity | 0.054 | ||||
| Return On Asset | 0.0339 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 1.21 B | ||||
| Shares Outstanding | 49.28 M | ||||
| Shares Owned By Insiders | 0.53 % | ||||
| Shares Owned By Institutions | 99.25 % | ||||
| Number Of Shares Shorted | 2.92 M | ||||
| Price To Earning | 460.83 X | ||||
| Price To Book | 3.29 X | ||||
| Price To Sales | 4.12 X | ||||
| Revenue | 322.42 M | ||||
| Gross Profit | 223.38 M | ||||
| EBITDA | 33.22 M | ||||
| Net Income | 21.35 M | ||||
| Cash And Equivalents | 202.49 M | ||||
| Cash Per Share | 4.22 X | ||||
| Total Debt | 35.83 M | ||||
| Debt To Equity | 0.10 % | ||||
| Current Ratio | 6.37 X | ||||
| Book Value Per Share | 8.69 X | ||||
| Cash Flow From Operations | 14.59 M | ||||
| Short Ratio | 4.30 X | ||||
| Earnings Per Share | 0.44 X | ||||
| Price To Earnings To Growth | (4.89) X | ||||
| Target Price | 42.98 | ||||
| Number Of Employees | 1.06 K | ||||
| Beta | 0.62 | ||||
| Market Capitalization | 1.41 B | ||||
| Total Asset | 488.69 M | ||||
| Retained Earnings | (47.37 M) | ||||
| Working Capital | 300.23 M | ||||
| Current Asset | 49.07 M | ||||
| Current Liabilities | 17.89 M | ||||
| Net Asset | 488.69 M |
About STAAR Surgical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze STAAR Surgical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of STAAR Surgical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of STAAR Surgical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 10.8 M | 10.3 M | |
| Total Revenue | 322.4 M | 338.5 M | |
| Cost Of Revenue | 69.8 M | 73.3 M | |
| Stock Based Compensation To Revenue | 0.06 | 0.04 | |
| Sales General And Administrative To Revenue | 0.19 | 0.17 | |
| Research And Ddevelopement To Revenue | 0.15 | 0.10 | |
| Capex To Revenue | 0.06 | 0.06 | |
| Revenue Per Share | 4.88 | 5.13 | |
| Ebit Per Revenue | 0.14 | 0.15 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether STAAR Surgical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STAAR Surgical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Staar Surgical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Staar Surgical Stock:Check out STAAR Surgical Piotroski F Score and STAAR Surgical Altman Z Score analysis. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.018 | Earnings Share 0.44 | Revenue Per Share 6.962 | Quarterly Revenue Growth 0.103 | Return On Assets 0.0339 |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.